Prolifagen, Inc.

CIK 2086999 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Prolifagen, Inc..

Recent SEC filings

FiledFormAccession number
Sep 23, 2025D0002086999-25-000001